Comparative Pharmacology
Head-to-head clinical analysis: CORTALONE versus DIPROLENE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CORTALONE versus DIPROLENE.
CORTALONE vs DIPROLENE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Cortisone is a corticosteroid that binds to glucocorticoid receptors, modulating gene expression to suppress inflammation and immune response, and regulate metabolism.
Topical corticosteroid with anti-inflammatory, antipruritic, and vasoconstrictive actions. Suppresses inflammation by inducing phospholipase A2 inhibitory proteins (lipocortins) and inhibiting release of arachidonic acid, thereby reducing prostaglandin and leukotriene synthesis.
10-40 mg orally once daily in the morning; for acute exacerbations, up to 60 mg/day divided into 2-4 doses.
Topical: Apply thin film to affected area once or twice daily. Maximum dose: 45 g/week.
None Documented
None Documented
Terminal elimination half-life is 3-5 hours in patients with normal renal function; prolonged to 12-24 hours in severe renal impairment (CrCl <30 mL/min).
Terminal elimination half-life is approximately 2-3 hours for the parent drug. However, due to high potency and tissue binding, clinical effects may persist longer. Context: used for short-term management.
Primarily renal (60-70% as unchanged drug), with 10-20% biliary/fecal.
Primarily metabolized in the liver; metabolites are excreted renally and fecally. Approximately 30-40% renally, 50-60% fecally. Biliary excretion minimal.
Category C
Category C
Topical Corticosteroid
Topical Corticosteroid